Wonjin Rhi
Family · Duluth, GANPI 1205488277
Payments from drug & device makers
Across 225 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$642
- Novo Nordisk$458
- AstraZeneca$434
- Amgen$405
- Lilly USA, LLC$367
- Amarin Pharma, Inc.$344
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,330100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $642 |
| Novo Nordisk | 21 | $458 |
| AstraZeneca | 19 | $434 |
| Amgen | 28 | $405 |
| Lilly USA, LLC | 21 | $367 |
| Amarin Pharma, Inc. | 22 | $344 |
| Sanofi-aventis U.S. LLC | 10 | $270 |
| Bayer | 5 | $191 |
| Astellas Pharma US Inc | 3 | $150 |
| Gilead | 3 | $118 |
| Dexcom, Inc. | 7 | $117 |
| Azurity Pharmaceuticals, Inc. | 5 | $105 |
| Radius Health, Inc. | 4 | $99 |
| Pfizer | 4 | $83 |
| Medtronic | 3 | $81 |
| VBI Vaccine (delaware) Inc. | 3 | $60 |
| Insulet Corporation | 2 | $41 |
| GSK | 2 | $41 |
| Merck | 3 | $39 |
| Vivus LLC | 3 | $39 |
| Boehringer Ingelheim | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,330 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 77 | $132,973 |
| FarxigaDapagliflozin Propanediol | 58 | $77,822 |
| VascepaIcosapent Ethyl | 82 | $77,049 |
| JardianceEmpagliflozin | 63 | $69,888 |
| CreonLipase/Protease/Amylase | 24 | $57,051 |
| OzempicSemaglutide | 43 | $54,223 |
| MounjaroTirzepatide | 27 | $33,110 |
| JanuviaSitagliptin Phosphate | 12 | $20,451 |
| VraylarCariprazine Hcl | 12 | $19,924 |
| Repatha SureclickEvolocumab | 11 | $11,599 |
| RestasisCyclosporine | 14 | $9,587 |
| JubliaEfinaconazole | 11 | $8,556 |
| Lidocaine | 37 | $5,175 |
| Omega-3 Acid Ethyl Esters | 24 | $4,655 |
| Diclofenac Sodium | 58 | $2,418 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $405 | $132,97377 claims |
| AbbVieCreon, Vraylar, Restasis | $642 | $86,56150 claims |
| AstraZenecaFarxiga | $434 | $77,82258 claims |
| Boehringer IngelheimJardiance | $38 | $69,88863 claims |
| Novo NordiskOzempic | $458 | $54,22343 claims |
| Lilly USA, LLCMounjaro | $367 | $33,11027 claims |
| MerckJanuvia | $39 | $20,45112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Duluth
- Stephanie HigdonDuluth$28K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.